Skip to main content

Three Solarvest Bioenergy Inc. Products Receive EU Organic Certification.

Tickers: XTSX:SVS
Tags: #AlternativeEnergy

Vancouver, BC - TheNewswier - July 18th. 2019 - SOLARVEST BIOENERGY INC. (TSXV:SVS) ("Solarvest" or the "Company"), is pleased to announce that it has received EU organic certification for three new products. First, the company's algae cream has been approved by Lacon GmbH, second, AB CERT AG has certified the high Omega 3 algae powder and third, the company's Gummy Drop (finished oral dosage form) has been organic approved by Ecocert IMO GmbH. The organic logo can only be used on products that have been certified and the European Commission (EC) sets the strict standards for organic production under Council Regulation EC No 834/2007. The EC approves and designates the European certifying bodies (noted above), who provide the audit and approval.

About Solarvest:

Solarvest is an algae technology company that owns numerous key patents. Our organic Omega-3 patent application has been filed and is pending in Europe, UK, USA, Canada, Japan, India, China, S. Korea, Hong Kong and Australia. Its patent pending process produces the world's first organic DHA & Omega-3. The company has been working with a contract manufacturer has achieved commercial yields and is poised to supply the $25 billion dollar global Omega-3 market. The Solarvest system grows the algae under closely controlled conditions ensuring that the health products are produced without the environmental contaminants found in our oceans. In addition, organic certification provides our customers the assurance that the products are GMO free, sustainable and produced without chemicals. Since they are algae based the products are suitable for vegetarian and vegan diets. Solarvest's FDA licensed organic Omega-3 products offer the consumer a healthy and sustainable product choice.

For further information contact:

Gerri Greenham, Chief Executive Officer

Tel: 416 420 0947 Email: ggreenham@solarvest.ca

The TSX Venture Exchange has neither approved nor disapproved the contents of this news release.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

The statements made in this news release may contain forward-looking statements that may involve a number of risks and uncertainties. Actual events or results could differ materially from the Company's expectations and projections.

Copyright (c) 2019 TheNewswire - All rights reserved.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.